AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENANTA PHARMACEUTICALS INC Director's Dealing 2021

Dec 3, 2021

33238_dirs_2021-12-03_17ec2740-856d-4116-87f5-0ad5d08092dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-12-01

Reporting Person: Luly Jay R. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-01	Common Stock	F	1944	$87.68	Disposed	700728	Direct

Footnotes

F1: Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 20, 2020.